Treatment of Mixed Mania with Risperidone and Mood Stabilizers

Marder SR Davis JM Chouinard G. The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: Combined results of the North American trials. J Clin Psychiatry 1997;58:538–46.

Peuskens J Van Baelen B De Smedt C Lemmens P. Effects of risperidone on affective symptoms in patients with schizophrenia. Int Clin Psychopharmacol 2000;15:343–9.

Simpson GM Lindenmayer JP . Extrapyramidal symptoms in patients treated with risperidone. J Clin Psychopharmacol 1997;17:194–201.

Gutierrez-Esteinou Grebb JA . Risperidone: An analysis of the first three years in general use. Int J Psychopharmacol 1997;12(Suppl 4):S3–10.

Sachs G. Safety and efficacy of risperidone vs placebo as add-on therapy to mood-stabilizers in the treatment of manic phase of bipolar disorder. Paper presented at the American College of Neuropsychopharmacology Meeting; December 1999; Acapulco.

Yatham L. Safety and efficacy of risperidone as combination therapy for the manic phase of bipolar disorder: Preliminary findings of a randomized, double-blind study (RIS-IN-46). Journal of Neuropsychopharmacology 2000;3(Suppl 1):S142.

Vieta E Gastó C Escobar R. Treatment of dysphoric mania with risperidone. Hum Psychopharmacol Clin 1995;10:491–2.